• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对于细胞学检查为阴性的妇女,除 16/18 型以外的高危型 HPV 的意义:真的可以安全等待 1 年吗?

The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?

机构信息

Department of Gynecologic Oncology, Zeynep Kamil Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

Department of Pathology, Zeynep Kamil Training and Research Hospital, University of Health Sciences, Istanbul, Turkey.

出版信息

Diagn Cytopathol. 2021 Apr;49(4):480-486. doi: 10.1002/dc.24705. Epub 2021 Feb 2.

DOI:10.1002/dc.24705
PMID:33528903
Abstract

BACKGROUND

Human papillomavirus (HPV) is a primary risk factor for cervical cancer. HPV 16 and 18 are the two most carcinogenic genotypes and have been reported in the majority of cervical cancer. High-risk HPVs (hrHPVs) other than HPV 16/18 cause approximately a quarter of cervical cancers. We aimed to present the colposcopy-guided biopsy results of non-16/18 hrHPV-infected women with negative cytology.

METHODS

This is a retrospective cohort study conducted on 752 patients between the ages of 30-65 years with non-16/18 hrHPV and negative cytology undergoing colposcopy-guided biopsy at a tertiary gynecological cancer center between January-2016 and January-2019.

RESULTS

The mean age of the women was 42.35±9.41 years. Cervical intraepithelial neoplasia (CIN) 2+ lesion was detected in 49 (6.5%) women with negative cytology. The rate of CIN 2+ lesions in women with abnormal cytology was 12.8%. Patients with abnormal cytology had about 2.1 and 2.4 times increased the odds of CIN 2+ lesion in cervical biopsy and endocervical curettage specimens, respectively. CIN 3+ lesion was detected in 20 (2.7%) women with negative cytology. One (0.1%) of the patients with HPV 39 and negative cytology had invasive cervical cancer. The two most common HPV subtypes were HPV 31 and HPV 51.

CONCLUSIONS

The risk of cervical preinvasive lesions still can be detected and cannot be completely eliminated among hrHPV other than 16/18-infected women with negative cytology. Based on the results of this study, referral of non-16/18 hrHPV-infected women with negative cytology to colposcopy is supported as a credible and feasible strategy.

摘要

背景

人乳头瘤病毒(HPV)是宫颈癌的主要危险因素。HPV16 和 18 是两种最具致癌性的基因型,在大多数宫颈癌中均有报道。除 HPV16/18 以外的高危型 HPV(hrHPV)约占宫颈癌的四分之一。我们旨在报告细胞学阴性的非 16/18hrHPV 感染妇女行阴道镜引导下活检的结果。

方法

这是一项回顾性队列研究,纳入了 2016 年 1 月至 2019 年 1 月在一家三级妇科癌症中心行阴道镜引导下活检的 752 例年龄在 30-65 岁之间的非 16/18hrHPV 且细胞学阴性的患者。

结果

女性的平均年龄为 42.35±9.41 岁。细胞学阴性的妇女中,有 49 例(6.5%)发现宫颈上皮内瘤变(CIN)2+病变。细胞学异常妇女的 CIN2+病变发生率为 12.8%。细胞学异常的患者,其在阴道镜活检和宫颈管搔刮标本中 CIN2+病变的优势比分别约为 2.1 和 2.4 倍。细胞学阴性的妇女中,有 20 例(2.7%)发现 CIN3+病变。1 例(0.1%)HPV39 且细胞学阴性的患者患有浸润性宫颈癌。最常见的两种 HPV 亚型为 HPV31 和 HPV51。

结论

在细胞学阴性的非 16/18hrHPV 感染妇女中,仍能检测到宫颈前病变的风险,且不能完全消除。基于本研究结果,支持将细胞学阴性的非 16/18hrHPV 感染妇女转诊至阴道镜检查作为一种可靠且可行的策略。

相似文献

1
The meaning of high-risk HPV other than type 16/18 in women with negative cytology: Is it really safe to wait for 1 year?对于细胞学检查为阴性的妇女,除 16/18 型以外的高危型 HPV 的意义:真的可以安全等待 1 年吗?
Diagn Cytopathol. 2021 Apr;49(4):480-486. doi: 10.1002/dc.24705. Epub 2021 Feb 2.
2
Is cervical cytology testing as a part of co-test unnecessary for HPV 16/18-infected women? A retrospective cohort study of 1647 women.HPV 16/18 感染女性行细胞学检测联合筛查是否有必要?一项 1647 例女性的回顾性队列研究。
Diagn Cytopathol. 2021 Feb;49(2):267-272. doi: 10.1002/dc.24633. Epub 2020 Oct 2.
3
Risk of cervical high-grade squamous intraepithelial neoplasia in cytologic negative and persistently high-risk human papillomavirus positive patients according to genotypes: a retrospective single center analysis.根据基因型,细胞学阴性且持续高危型人乳头瘤病毒阳性患者发生宫颈高级别鳞状上皮内瘤变的风险:一项回顾性单中心分析。
BMC Infect Dis. 2024 Jun 4;24(1):558. doi: 10.1186/s12879-024-09449-z.
4
Human papillomavirus test with cytology triage in organized screening for cervical cancer.在宫颈癌组织筛查中采用人乳头瘤病毒检测及细胞学分流
Acta Obstet Gynecol Scand. 2016 Nov;95(11):1220-1227. doi: 10.1111/aogs.13013.
5
Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.德国引入新的宫颈癌筛查后,持续高危型人乳头瘤病毒阳性、细胞学阴性女性中高级别上皮内瘤变的流行率。
Cancer Causes Control. 2023 May;34(5):469-477. doi: 10.1007/s10552-023-01677-z. Epub 2023 Feb 28.
6
Reflex Human Papillomavirus Test Results as an Option for the Management of Korean Women With Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion.反射性人乳头瘤病毒检测结果作为韩国非典型鳞状细胞女性管理的一种选择不能排除高级别鳞状上皮内病变。
Oncologist. 2015 Jun;20(6):635-9. doi: 10.1634/theoncologist.2014-0459. Epub 2015 May 11.
7
Prevalence of HPV-16/18 genotypes and immediate histopathologic correlation results in a Chinese population with negative cytology and positive high-risk HPV testing.在中国人群中,细胞学阴性而高危型 HPV 检测阳性者的 HPV-16/18 基因型流行率及即刻组织病理学相关性结果。
Cancer Cytopathol. 2019 Oct;127(10):650-657. doi: 10.1002/cncy.22180. Epub 2019 Sep 18.
8
[Evaluation of CIN2+ /CIN3+ risk of different HPV subtypes infection combined with abnormal cytology status].[不同HPV亚型感染合并细胞学异常状态下CIN2+/CIN3+风险的评估]
Zhonghua Zhong Liu Za Zhi. 2018 Mar 23;40(3):232-238. doi: 10.3760/cma.j.issn.0253-3766.2018.03.015.
9
[Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].[卫生技术评估报告:基于人乳头瘤病毒DNA的宫颈癌前病变初筛]
Epidemiol Prev. 2012 May-Aug;36(3-4 Suppl 1):e1-72.
10
[Results and cost evaluation of triage with high risk HPV test in cervical cancer screening. A pilot study in Piedmont (North-West Italy)].[宫颈癌筛查中高危型人乳头瘤病毒检测分诊的结果与成本评估:皮埃蒙特(意大利西北部)的一项试点研究]
Epidemiol Prev. 2012 Mar-Apr;36(2):88-94.

引用本文的文献

1
Vaccines in Dermatology-Present and Future: A Review.皮肤病学中的疫苗:现状与未来综述
Vaccines (Basel). 2025 Jan 26;13(2):125. doi: 10.3390/vaccines13020125.
2
Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.细胞学阴性的 HPV 致癌女性中宫颈上皮内瘤变的即刻风险和阴道镜检查的诊断价值:一项回顾性研究。
BMC Womens Health. 2024 Jul 24;24(1):419. doi: 10.1186/s12905-024-03258-x.
3
High-Risk Genotypes of Human Papillomavirus at Diverse Anogenital Sites among Chinese Women: Infection Features and Potential Correlation with Cervical Intraepithelial Neoplasia.
中国女性不同肛门生殖器部位人乳头瘤病毒的高危基因型:感染特征及与宫颈上皮内瘤变的潜在相关性
Cancers (Basel). 2024 May 31;16(11):2107. doi: 10.3390/cancers16112107.
4
High-risk HPV prevalence and vaccination coverage among Indigenous women in the Colombian Amazon: Implications for cervical cancer prevention. Cross-sectional study.哥伦比亚亚马逊地区原住民女性的高危型人乳头瘤病毒感染率及疫苗接种覆盖率:对宫颈癌预防的启示。横断面研究。
PLoS One. 2024 Feb 5;19(2):e0297579. doi: 10.1371/journal.pone.0297579. eCollection 2024.
5
Prevalence of higher-grade dysplasia in persistently high-risk human papillomavirus positive, cytology negative women after introduction of the new cervical cancer screening in Germany.德国引入新的宫颈癌筛查后,持续高危型人乳头瘤病毒阳性、细胞学阴性女性中高级别上皮内瘤变的流行率。
Cancer Causes Control. 2023 May;34(5):469-477. doi: 10.1007/s10552-023-01677-z. Epub 2023 Feb 28.